Laura McKnight
Jeff McKnight, a molecular biologist at the University of Oregon, died in October at the age of 36.
McKnight’s research focused on chromatin, a complex of DNA and proteins that controls when and how DNA can be accessed for replication and gene expression. He was one of the earliest researchers in the world capable of directly manipulating its structure, stemming back to his postdoctoral work at the Fred Hutchinson Cancer Research Center using the model organism
Saccharomyces cerevisiae. When he had started his own lab in 2016, McKnight said at the time that his “real dream” was to apply his work to the dozens of human diseases that involve some level of chromatin disruption, including Parkinson’s, Alzheimer’s, and Huntington’s.
An advisory committee to the U.S. Food and Drug Administration has given a thumbs up to the nation s second COVID-19 vaccine.
The independent Vaccines and Related Biological Products Advisory Committee voted 20-0 with one abstention to support mRNA-1273, a vaccine made in collaboration with the U.S. government by Moderna, a decade-old Cambridge, Massachusetts-based biotechnology company. There s no doubt in my mind – it looks like the benefits outweigh the risks from what I ve seen, said Dr. Steven Pergam, a committee member and infectious disease and vaccine expert at the Fred Hutchinson Cancer Research Center in Seattle, expressing the group s consensus.
Expert panel votes FDA SHOULD give Moderna s COVID-19 vaccine emergency approval amid hopes the U.S will soon have a second shot to help get 20 million Americans vaccinated by the end of 2020
A panel of FDA experts voted that the agency should approve Moderna s coronavirus vaccine and recommend whether the shot should be approved
With their endorsement, Moderna s shot will almost certainly get emergency approval tonight or tomorrow
Two people in Moderna s trial had severe allergic reactions: one who got a placebo, and a vaccine recipient who had anaphylactic shock 63 days later
Moderna determined neither were linked to the shot, and allergic reactions are generally immediate, not months later
An advisory committee to the U.S. Food and Drug Administration has given a thumbs up to the nation s second COVID-19 vaccine.
The independent Vaccines and Related Biological Products Advisory Committee voted 20-0 with one abstention to support mRNA-1273, a vaccine made in collaboration with the U.S. government by Moderna, a decade-old Cambridge, Massachusetts-based biotechnology company. There s no doubt in my mind – it looks like the benefits outweigh the risks from what I ve seen, said Dr. Steven Pergam, a committee member and infectious disease and vaccine expert at the Fred Hutchinson Cancer Research Center in Seattle, expressing the group s consensus.